No quarterly revenue total was found in SNOWDRIFT PARENT CORPORATION's SEC filings.
Snowdrift Parent Corporation (CMMB) files with the SEC under industry code 2834, Pharmaceutical Preparations. Free cash flow was -$7.2 million. As of Dec 31, 2025 it held $7.6 million in cash and investments and $0 in total debt.
Revenue
—
Net income
$-8.75M
-71.5% vs year-ago quarter
Operating cash flow
$-7.19M
-93.6% vs year-ago quarter
Free cash flow
$-7.19M
-92.9% vs year-ago quarter
EPS
$0.04
+209.0% vs prior quarter
Dividend per share
None
Shares outstanding
575.38M
+52.6% vs year-ago quarter
Net cash
$7.56M
Q4 FY2025
Operating margin
—
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CMMB (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- Israel
- Headquarters
- Tel Aviv
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1534248
- Former names
- Anchiano Therapeutics Ltd. (until Mar 17, 2021); BioCancell Ltd. (until Nov 3, 2015)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Key figures
Fiscal-year totals from the annual reports; switch to Annual for the full-year view. Balance sheet lines are as of each year end.
| Line | Q1 FY2023 Mar 31, 2023 |
Q4 FY2022 Dec 31, 2022 |
Q3 FY2022 Sep 30, 2022 |
Q2 FY2022 Jun 30, 2022 |
Q1 FY2022 Mar 31, 2022 |
|---|---|---|---|---|---|
| Net income | -$8.8M | -$8.3M | -$8.1M | -$6.2M | -$5.1M |
| Diluted EPS | $0.04 | -$0.04 | $0.04 | $0.03 | — |
| Operating cash flow | -$7.2M | -$5.7M | -$5.3M | -$5.7M | -$3.7M |
| Free cash flow | -$7.2M | -$5.7M | -$5.3M | -$5.7M | -$3.7M |
| Total assets | $35.0M | $43.1M | $50.2M | $56.4M | $61.0M |
| Total liabilities | $7.1M | $6.8M | $5.6M | $4.5M | $3.7M |
| Stockholders' equity | $28.0M | $36.2M | $44.6M | $51.8M | $57.2M |
| Cash and investments | $20.8M | $13.5M | $10.7M | $9.9M | $13.8M |
| Total debt | $177,000 | $214,000 | $244,000 | $280,000 | $319,000 |
Recent SEC filings
| Form | Description | Filed | Period |
|---|---|---|---|
| 6-K | Current report (foreign issuer) | Nov 3, 2026 | Nov 3, 2026 |
| 6-K | Current report (foreign issuer) | Oct 19, 2026 | Oct 19, 2026 |
| 6-K | Current report (foreign issuer) | Sep 30, 2026 | Sep 30, 2026 |
| 6-K | Current report (foreign issuer) | Aug 19, 2026 | Jun 30, 2026 |
| 6-K | Current report (foreign issuer) | Jul 8, 2026 | Jul 8, 2026 |
| 6-K | Current report (foreign issuer) | Jun 2, 2026 | Jun 2, 2026 |
All 366 Snowdrift Parent Corporation SEC filings
Source: SEC EDGAR filings. This is company-reported data, not investment advice.